Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

129 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
First ex vivo validation of a radioguided surgery technique with β-radiation.
Solfaroli Camillocci E, Schiariti M, Bocci V, Carollo A, Chiodi G, Colandrea M, Collamati F, Cremonesi M, Donnarumma R, Ferrari ME, Ferroli P, Ghielmetti F, Grana CM, Mancini Terracciano C, Marafini M, Morganti S, Patanè M, Pedroli G, Pollo B, Recchia L, Russomando A, Toppi M, Traini G, Faccini R. Solfaroli Camillocci E, et al. Among authors: patane m. Phys Med. 2016 Sep;32(9):1139-44. doi: 10.1016/j.ejmp.2016.08.018. Epub 2016 Sep 2. Phys Med. 2016. PMID: 27601248
The β- radio-guided surgery: Method to estimate the minimum injectable activity from ex-vivo test.
Russomando A, Schiariti M, Bocci V, Colandrea M, Collamati F, Cremonesi M, Ferrari ME, Ferroli P, Ghielmetti F, Ghisini R, Grana CM, Mancini Terracciano C, Marafini M, Mirabelli R, Morganti S, Papi S, Patanè M, Pedroli G, Pollo B, Solfaroli Camillocci E, Traini G, Faccini R. Russomando A, et al. Among authors: patane m. Phys Med. 2019 Feb;58:114-120. doi: 10.1016/j.ejmp.2019.02.004. Epub 2019 Feb 16. Phys Med. 2019. PMID: 30824142
Are Thalamic Intrinsic Lesions Operable? No-Man's Land Revisited by the Analysis of a Large Retrospective, Mono-Institutional, Cohort.
Ferroli P, Restelli F, Bertolini G, Monti E, Falco J, Bonomo G, Tramacere I, Pollo B, Calatozzolo C, Patanè M, Schiavolin S, Broggi M, Acerbi F, Erbetta A, Esposito S, Mazzapicchi E, La Corte E, Vetrano IG, Broggi G, Schiariti M. Ferroli P, et al. Among authors: patane m. Cancers (Basel). 2023 Jan 5;15(2):361. doi: 10.3390/cancers15020361. Cancers (Basel). 2023. PMID: 36672311 Free PMC article.
Constitutive and TNFα-inducible expression of chondroitin sulfate proteoglycan 4 in glioblastoma and neurospheres: Implications for CAR-T cell therapy.
Pellegatta S, Savoldo B, Di Ianni N, Corbetta C, Chen Y, Patané M, Sun C, Pollo B, Ferrone S, DiMeco F, Finocchiaro G, Dotti G. Pellegatta S, et al. Among authors: patane m. Sci Transl Med. 2018 Feb 28;10(430):eaao2731. doi: 10.1126/scitranslmed.aao2731. Sci Transl Med. 2018. PMID: 29491184 Free PMC article.
High tumor mutational burden and T-cell activation are associated with long-term response to anti-PD1 therapy in Lynch syndrome recurrent glioblastoma patient.
Anghileri E, Di Ianni N, Paterra R, Langella T, Zhao J, Eoli M, Patanè M, Pollo B, Cuccarini V, Iavarone A, Rabadan R, Finocchiaro G, Pellegatta S. Anghileri E, et al. Among authors: patane m. Cancer Immunol Immunother. 2021 Mar;70(3):831-842. doi: 10.1007/s00262-020-02769-4. Epub 2020 Nov 3. Cancer Immunol Immunother. 2021. PMID: 33140187 Free PMC article.
Deciphering the Labyrinthine System of the Immune Microenvironment in Recurrent Glioblastoma: Recent Original Advances and Lessons from Clinical Immunotherapeutic Approaches.
Anghileri E, Patanè M, Di Ianni N, Sambruni I, Maffezzini M, Milani M, Maddaloni L, Pollo B, Eoli M, Pellegatta S. Anghileri E, et al. Among authors: patane m. Cancers (Basel). 2021 Dec 7;13(24):6156. doi: 10.3390/cancers13246156. Cancers (Basel). 2021. PMID: 34944776 Free PMC article. Review.
129 results